AI Verdict
IMKTA has stronger fundamentals based on our AI analysis.
IMKTA vs IMDX Fundamental Comparison
| Metric | IMKTA | IMDX |
|---|---|---|
| Revenue | $1.4B | $4.1M |
| Net Income | $28.1M | $-50.2M |
| Net Margin | 2.0% | -1,238.5% |
| ROE | 1.7% | N/A |
| ROA | 1.1% | -195.0% |
| Current Ratio | 3.36x | 1.27x |
| Debt/Equity | 0.30x | N/A |
| EPS | N/A | $-1.65 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
IMKTA vs IMDX: Frequently Asked Questions
Is IMKTA or IMDX a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), IMKTA has stronger fundamentals. IMKTA is rated SELL (72% confidence) while IMDX is rated STRONG SELL (88% confidence). This is not investment advice.
How does IMKTA compare to IMDX fundamentally?
INGLES MARKETS INC has ROE of 1.7% vs Insight Molecular Diagnostics Inc.'s N/A. Net margins are 2.0% vs -1,238.5% respectively.
Which stock pays higher dividends, IMKTA or IMDX?
IMKTA has a dividend yield of N/A or no dividend while IMDX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in IMKTA or IMDX for long term?
For long-term investing, consider that IMKTA has SELL rating with 72% confidence, while IMDX has STRONG SELL rating with 88% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about IMKTA vs IMDX?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For IMKTA vs IMDX, the AI consensus favors IMKTA based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.